학술논문
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3ITD mutations: results of the SAL MIDOKIT trial
Document Type
Article
Author
Ruhnke, L.; Röllig, C.; Schetelig, J.; Stölzel, F.; Kramer, M.; Haake, A.; Frimmel, J.; Bornhäuser, M.; Ehninger, G.; Thiede, C.; Herold, S.; Aust, D.; Sauer, T.; Krämer, A.; Schlenk, R.; Müller-Tidow, C.; Brandts, C.H.; Steffen, B.; Serve, H.; Schäfer-Eckart, K.; Krause, S.W.; Hänel, M.; Reichle, A.; Scholl, S.; Neubauer, A.; Mikesch, J.-H.; Platzbecker, U.; Baldus, C.D.
Source
In: Haematologica . (Haematologica, September 2023, 108(9):2520-2525)
Subject
Language
English
ISSN
15928721
03906078
03906078